Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FA947
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,811
Award facts
- Contract value 100% obligated
- $18,811.00 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,811.00 to AmerisourceBergen Drug Corp under contract 4570183663 on December 4, 2025, with an ultimate completion date of the same day. This firm fixed price delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this competitive award.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical medical procurement needs for military and veteran healthcare systems through its extensive federal contract portfolio. Under the parent IDC vehicle, the company supplies a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The DLA Troop Support Medical contract serves as a flexible procurement mechanism enabling AmerisourceBergen to meet diverse federal medical supply requirements while DLA pursues a strategic transition toward its Pharmaceutical Prime Vendor Global Program Generation V initiative, which is expected to involve multiple regional awards among competing contractors.
Quick answers
Who was awarded contract SPE2DU26FA947?
SPE2DU26FA947 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DU26FA947 worth?
The government has obligated $18,811 on SPE2DU26FA947.
Is contract SPE2DU26FA947 an order under another contract?
Yes. SPE2DU26FA947 is a delivery order under SPE2DU25D4210, an indefinite delivery contract.
Was contract SPE2DU26FA947 competed?
The extent of competition for SPE2DU26FA947 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award